Tarun Mandal to Excipients
This is a "connection" page, showing publications Tarun Mandal has written about Excipients.
Connection Strength
1.074
-
Devanga-Chinta D, Graves RA, Pamujula S, Mandal TK. Controlled release multiple layer coatings. Drug Dev Ind Pharm. 2010 Feb; 36(2):200-8.
Score: 0.356
-
Chinta DD, Graves RA, Pamujula S, Praetorius N, Bostanian LA, Mandal TK. Spray-dried chitosan as a direct compression tableting excipient. Drug Dev Ind Pharm. 2009 Jan; 35(1):43-8.
Score: 0.330
-
Pramar YV, Graves RA, Ledet GA, Phan KV, Bostanian LA, Mandal TK. Stability of Clindamycin Hydrochloride in PCCA Base SuspendIt. Int J Pharm Compd. 2016 Sep-Oct; 20(5):421-425.
Score: 0.140
-
Ledet G, Pamujula S, Walker V, Simon S, Graves R, Mandal TK. Development and in vitro evaluation of a nanoemulsion for transcutaneous delivery. Drug Dev Ind Pharm. 2014 Mar; 40(3):370-9.
Score: 0.111
-
Pramar YV, Mandal TK, Bostanian LA, Kader C, Morris TC, Graves RA. Physicochemical and Microbiological Stability of Amitriptyline Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt. Int J Pharm Compd. 2022 Jul-Aug; 26(4):342-351.
Score: 0.053
-
Mandal TK. Swelling-controlled release system for the vaginal delivery of miconazole. Eur J Pharm Biopharm. 2000 Nov; 50(3):337-43.
Score: 0.047
-
Powell D, Chandra S, Dodson K, Shaheen F, Wiltz K, Ireland S, Syed M, Dash S, Wiese T, Mandal T, Kundu A. Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer. Eur J Pharm Biopharm. 2017 May; 114:108-118.
Score: 0.036